IP Library Granted Patent US 12,636,436
Granted Patent B2
US 12,636,436 · App. 18/163,718 · Granted May 26, 2026

Sensor data calibration based on weighted values

Inventors: Desmond Barry Keenan (Hollywood, CA); John J. Mastrototaro (Los Angeles, CA)
Assignee: Medtronic MiniMed, Inc.
A61M5/1723A61B5/14532G16B20/00G16H10/40G16H20/17G16H40/40G16H40/63A61B2560/0223A61M2230/005A61M2230/201
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,636,436
App. No.
18/163,718
Granted
May 26, 2026
Kind
B2
Abstract

Disclosed herein are techniques related to sensor data calibration based on weighted values. In some embodiments, the techniques involve obtaining a plurality of sample values of an electrical signal generated by a sensor. Each sample value may be indicative of a concentration of an analyte in a first type of bodily fluid. Additionally, the techniques may involve obtaining a plurality of reference measurement values (RMVs). Each RMV may correspond to a concentration of the analyte in a second type of bodily fluid. The techniques may also involve temporally associating a first sample value to a first RMV and a second sample value to a second RMV, which is greater than the first RMV. The techniques may further involve applying a first weighting to the first sample value and a second weighting to the second sample value. The first weighting may be greater than the second weighting.

Claims (55)

1 . A processor-implemented method for calibration, the method comprising:

obtaining a plurality of sample values of an electrical signal generated by a sensor, each sample value of the plurality of sample values being indicative of a concentration of an analyte in a first type of bodily fluid of a patient;

obtaining a plurality of reference measurement values, each reference measurement value of the plurality of reference measurement values corresponding to a concentration of the analyte in a second type of bodily fluid of the patient;

temporally associating a first sample value of the plurality of sample values to a first reference measurement value of the plurality of reference measurement values;

temporally associating a second sample value of the plurality of sample values to a second reference measurement value of the plurality of reference measurement values, the second reference measurement value being greater than the first reference measurement value;

applying a first weighting to the first sample value to generate a first weighted sample value;

applying a second weighting to the second sample value to generate a second weighted sample value, wherein the first weighting is greater than the second weighting;

determining a calibration factor based, at least in part, on the first weighted sample value and the second weighted sample value; and

calibrating a value of the electrical signal to correspond to an estimated concentration of the analyte in the second type of bodily fluid based on applying the calibration factor to the value of the electrical signal.

2 . The method of claim 1 , wherein the first type of bodily fluid is interstitial fluid.

3 . The method of claim 1 , wherein the second type of bodily fluid is blood.

4 . The method of claim 1 , wherein the analyte is glucose.

5 . The method of claim 1 , wherein determining the calibration factor comprises determining a linear regression based on at least the first weighted sample value, the second weighted sample value, the first reference measurement value, and the second reference measurement value.

6 . The method of claim 1 , wherein determining the calibration factor comprises:

determining a linear regression sensitivity ratio based, at least in part, on the first weighted sample value, the second weighted sample value, the first reference measurement value and the second reference measurement value;

selecting an offset based, at least in part, on the determined linear regression sensitivity ratio; and

determining a modified linear regression sensitivity ratio based, at least in part, on the selected offset, the first weighted sample value, the second weighted sample value, the first reference measurement value, and the second reference measurement value.

7 . The method of claim 1 , wherein determining the calibration factor comprises determining a linear relationship based on at least the first weighted sample value and the second weighted sample value.

8 . A system comprising:

one or more processors; and

one or more processor-readable media storing instructions which, when executed by the one or more processors, cause performance of:

obtaining a plurality of sample values of an electrical signal generated by a sensor, each sample value of the plurality of sample values being indicative of a concentration of an analyte in a first type of bodily fluid of a patient;

obtaining a plurality of reference measurement values, each reference measurement value of the plurality of reference measurement values corresponding to a concentration of the analyte in a second type of bodily fluid of the patient;

temporally associating a first sample value of the plurality of sample values to a first reference measurement value of the plurality of reference measurement values;

temporally associating a second sample value of the plurality of sample values to a second reference measurement value of the plurality of reference measurement values, the second reference measurement value being greater than the first reference measurement value;

applying a first weighting to the first sample value to generate a first weighted sample value;

applying a second weighting to the second sample value to generate a second weighted sample value, wherein the first weighting is greater than the second weighting;

determining a calibration factor based, at least in part, on the first weighted sample value and the second weighted sample value; and

calibrating a value of the electrical signal to correspond to an estimated concentration of the analyte in the second type of bodily fluid based on applying the calibration factor to the value of the electrical signal.

9 . The system of claim 8 , wherein the first type of bodily fluid is interstitial fluid.

10 . The system of claim 8 , wherein the second type of bodily fluid is blood.

11 . The system of claim 8 , wherein the analyte is glucose.

12 . The system of claim 8 , wherein determining the calibration factor comprises determining a linear regression of at least the first weighted sample value, the second weighted sample value, the first reference measurement value, and the second reference measurement value.

13 . The system of claim 8 , wherein determining the calibration factor comprises:

determining a linear regression sensitivity ratio based, at least in part, on the first weighted sample value, the second weighted sample value, the first reference measurement value and the second reference measurement value;

selecting an offset based, at least in part, on the determined linear regression sensitivity ratio; and

determining a modified linear regression sensitivity ratio based, at least in part, on the selected offset, the first weighted sample value, the second weighted sample value, the first reference measurement value, and the second reference measurement value.

14 . The system of claim 8 , wherein determining the calibration factor comprises determining a linear relationship based on at least the first weighted sample value and the second weighted sample value.

15 . One or more non-transitory processor-readable media storing instructions, which, when executed by one or more processors, cause performance of:

obtaining a plurality of sample values of an electrical signal generated by a sensor, each sample value of the plurality of sample values being indicative of a concentration of an analyte in a first type of bodily fluid of a patient;

obtaining a plurality of reference measurement values, each reference measurement value of the plurality of reference measurement values corresponding to a concentration of the analyte in a second type of bodily fluid of the patient;

temporally associating a first sample value of the plurality of sample values to a first reference measurement value of the plurality of reference measurement values;

temporally associating a second sample value of the plurality of sample values to a second reference measurement value of the plurality of reference measurement values, the second reference measurement value being greater than the first reference measurement value;

applying a first weighting to the first sample value to generate a first weighted sample value;

applying a second weighting to the second sample value to generate a second weighted sample value, wherein the first weighting is greater than the second weighting;

determining a calibration factor based, at least in part, on the first weighted sample value and the second weighted sample value; and

calibrating a value of the electrical signal to correspond to an estimated concentration of the analyte in the second type of bodily fluid based on applying the calibration factor to the value of the electrical signal.

16 . The one or more non-transitory processor-readable media of claim 15 , wherein the first type of bodily fluid is interstitial fluid.

17 . The one or more non-transitory processor-readable media of claim 15 , wherein the second type of bodily fluid is blood.

18 . The one or more non-transitory processor-readable media of claim 15 , wherein determining the calibration factor comprises determining a linear regression of at least the first weighted sample value, the second weighted sample value, the first reference measurement value, and the second reference measurement value.

19 . The one or more non-transitory processor-readable media of claim 15 , wherein determining the calibration factor comprises:

determining a linear regression sensitivity ratio based, at least in part, on the first weighted sample value, the second weighted sample value, the first reference measurement value and the second reference measurement value;

selecting an offset based, at least in part, on the determined linear regression sensitivity ratio; and

determining a modified linear regression sensitivity ratio based, at least in part, on the selected offset, the first weighted sample value, the second weighted sample value, the first reference measurement value, and the second reference measurement value.

20 . The one or more non-transitory processor-readable media of claim 15 , wherein determining the calibration factor comprises determining a linear relationship based on at least the first weighted sample value and the second weighted sample value.

Assignments (2)
SECURITY INTEREST Recorded Jan 16, 2026
From: MEDTRONIC MINIMED, INC.; COMPANION MEDICAL, INC.
To: CITIBANK, N.A.
Reel/Frame 074394/0237 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 2, 2023
From: KEENAN, DESMOND BARRY; MASTROTOTARO, JOHN J.
To: MEDTRONIC MINIMED, INC.
Reel/Frame 062576/0693 →
Continuity (4)
Continuation 16666119 · Oct 28, 2019
Continuation 15018702 · Feb 8, 2016
Continuation 12345477 · Dec 29, 2008
Related Publication 20230181825A1 · Jun 15, 2023
References Cited (74)
US 4562751A · Nason et al. · 1986 [cited by applicant]
US 4573994A · Fischell et al. · 1986 [cited by applicant]
US 4678408A · Nason et al. · 1987 [cited by applicant]
US 4685903A · Cable et al. · 1987 [cited by applicant]
US 5299571A · Mastrototaro · 1994 [cited by applicant]
US 5390671A · Lord et al. · 1995 [cited by applicant]
US 5391250A · Cheney, II et al. · 1995 [cited by applicant]
US 5399571A · Yamamoto et al. · 1995 [cited by applicant]
US 5482473A · Lord et al. · 1996 [cited by applicant]
US 5586553A · Halili et al. · 1996 [cited by applicant]
US 5951521A · Mastrototaro et al. · 1999 [cited by applicant]
US 5954643A · Van Antwerp et al. · 1999 [cited by applicant]
US 6360888B1 · McIvor et al. · 2002 [cited by applicant]
US 6368141B1 · VanAntwerp et al. · 2002 [cited by applicant]
US 6424847B1 · Mastrototaro · 2002 [cited by examiner]
US 6641533B2 · Causey, III et al. · 2003 [cited by applicant]
US 6895263B2 · Shin et al. · 2005 [cited by applicant]
US 7029444B2 · Shin et al. · 2006 [cited by applicant]
US 7324012B2 · Mann et al. · 2008 [cited by applicant]
US 7389133B1 · Kotulla et al. · 2008 [cited by applicant]
US 7405055B2 · Dunn et al. · 2008 [cited by applicant]
US 7890295B2 · Shin · 2011 [cited by examiner]
US 9289168B2 · Keenan et al. · 2016 [cited by applicant]
US 10471207B2 · Keenan et al. · 2019 [cited by applicant]
US 20020161288A1 · Shin et al. · 2002 [cited by applicant]
US 20050027177A1 · Shin et al. · 2005 [cited by applicant]
US 20080208173A1 · Lee et al. · 2008 [cited by applicant]
US 20080312845A1 · Hayter et al. · 2008 [cited by applicant]
US 20200078517A1 · Keenan et al. · 2020 [cited by applicant]
CN 102264283A · 2011 [cited by applicant]
WO 1998021246A1 · 1998 [cited by applicant]
U.S. Appl. No. 60/121,655 / PD-0332-PRO: Provisional application as filed on Feb. 25, 1999, 33 pages. [cited by applicant]
U.S. Appl. No. 60/121,656 / PD-0333-PRO: Provisional application as filed on Feb. 25, 1999, 26 pages. [cited by applicant]
U.S. Appl. No. 60/121,664 / PD-0331-PRO: Provisional application as filed on Feb. 25, 1999, 22 pages. [cited by applicant]
CA27 45090 / 115. P002PCTCA: Amendment/Remarks in Response to Examiner's Report, Apr. 7, 2016, 23 pages. [cited by applicant]
CN200980153109 / 115.P002PCTCN: First Office Action, 1112612012, 6 pages. [cited by applicant]
CN200980153109 / 115.P002PCTCN: Notification to Grant Patent Right for Invention, Apr. 4, 2014, 2 pages. [cited by applicant]
CN200980153109 / 115.P002PCTCN: Second Office Action, 0412612013, 5 pages. [cited by applicant]
CN200980153109 / 115.P002PCTCN: Third Office Action, 1112012013,6 pages. [cited by applicant]
CN2014102765.4/ 115.P002CPCTCND: First Office Action English Translation, Oct. 16, 2015, 10 pages. [cited by applicant]
CN201410276515.41 / 115.P002PCTCND: Second Office Action, 0513012016 5 pages. [cited by applicant]
CN201410276515.41 / 115.POOPCTCND: First Office Action English Translation, 1010812015, 6 pages. [cited by applicant]
CN201410276515.41 / 115.POOPCTCND: Notification to Grant Patent Right for Invention, 2 pages. [cited by applicant]
EP09801592.9 / 115.P002EP: Copy of amended claims filed with nationalized EP application, filed Jun. 8, 2011, 8 pages. [cited by applicant]
EP09801592.9 / 115.P002EP: Epo communication regarding written opinion/amendment mailed Aug. 5, 2011, 2 pages. [cited by applicant]
EP09801592.91 / 115.P002EP: Amended Claims, Oct. 8, 2018, 5 pages. [cited by applicant]
EP09801592.91 / 115.P002EP: Communication pursuant to Article 94(3) EPC, Oct. 9, 2017, 6 pages. [cited by applicant]
EP09801592.91 / 115.P002EP: Decision to grant patent, Mar. 28, 2019, 2 pages. [cited by applicant]
EP09801592.91 / 115.P002EP: EPO Communication under Rule 71 (3) EPC, Nov. 5, 2018, 116 pages. [cited by applicant]
EP09801592.91 / 115.P002EP: Response to EPO communication of Mar. 22, 2018, Sep. 14, 2018, 30 pages. [cited by applicant]
EP09801592.91 / 115.P002EP: Response to EPO communication of Aug. 5, 2011, Feb. 1, 2012, 16 pages. [cited by applicant]
EP09801592.91 / 115.P002EP: Response to EPO communication of Oct. 9, 2017, Jan. 18, 2018, 12 pages. [cited by applicant]
EP09801592.91 / 115.P002EP: Summons to attend oral proceedings pursuant to Rule 115(1) EPC, Mar. 22, 2018, 10 pages. [cited by applicant]
EP19161466.81 115.P002PCTEPD: European Search Report, Jun. 19, 2019,5 pages. [cited by applicant]
Notice of Allowance from U.S. Appl. No. 16/666,119 dated Oct. 6, 2022, 11 pp. [cited by applicant]
Notice of Intent to Grant and Text Intended to Grant from counterpart European Application No. 19161466.8, dated Sep. 2, 2020, 104 pp. [cited by applicant]
PCT/US2009/006677 / 115.P002PCT: PCT application as filed on Dec. 22, 2009, 55 pages. [cited by applicant]
PCT/US2009/006677 / 115.P002PCT: Initial Publication with International Search Report on Jul. 8, 2010, 57 pages. [cited by applicant]
PCT/US2009/006677 / 115.P002PCT: International Preliminary Report on Patentability mailed Jun. 29, 2011, 6 pages. [cited by applicant]
PCT/US2009/006677 / 115.P002PCT: International Search Report mailed Mar. 29, 2010, 3 pages. [cited by applicant]
PCT/US2009/006677 / 115.P002PCT: Written Opinion of the International Search Authority, mailed Jun. 29, 2011, 5 pages. [cited by applicant]
Prosecution History from U.S. Appl. No. 12/345,477, now issued U.S. Pat. No. 9,289,168, dated Jul. 21, 2011 through Nov. 6, 2015, 173 pp. [cited by applicant]
Prosecution History from U.S. Appl. No. 15/018,702, now issued U.S. Pat. No. 10,471,207, dated Nov. 28, 2018 through Oct. 8, 2019, 53 pp. [cited by applicant]
Prosecution History from U.S. Appl. No. 16/666,119, dated Oct. 28, 2019 through Oct. 6, 2022, 68 pp. [cited by applicant]
International Preliminary Report on Patentability dated Jul. 7, 2011 in Application No. PCT/US2009/006677. [cited by applicant]
U.S. Advisory Action dated Jun. 22, 2015, in U.S. Appl. No. 12/345,477, 3 pages. [cited by applicant]
U.S. Advisory Action dated May 1, 2012, in U.S. Appl. No. 12/345,477. [cited by applicant]
U.S. Final Office Action dated Feb. 1, 2012, in U.S. Appl. No. 12/345,477. [cited by applicant]
U.S. Final Office Action dated Mar. 30, 2015, in U.S. Appl. No. 12/345,477. [cited by applicant]
U.S. Non-Final Office Action dated Aug. 13, 2014, in U.S. Appl. No. 12/345,477. [cited by applicant]
U.S. Non-Final Office Action dated Jun. 21, 2011, in U.S. Appl. No. 12/345,477. [cited by applicant]
U.S. Non-Final Office Action dated Nov. 28, 2018, in U.S. Appl. No. 15/018,702. [cited by applicant]
U.S. Notice of Allowance dated Jul. 10, 2019, in U.S. Appl. No. 15/018,702. [cited by applicant]
U.S. Notice of Allowance dated Nov. 6, 2015 in U.S. Appl. No. 12/345,477. [cited by applicant]